{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:49:56Z","timestamp":1767707396092,"version":"build-2065373602"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007135","name":"University of Tennessee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007135","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.josat.2023.209153","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T01:36:58Z","timestamp":1694223418000},"page":"209153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Non-prescribing clinicians' treatment orientations and attitudes toward treatments for opioid use disorder: Rural differences"],"prefix":"10.1016","volume":"155","author":[{"given":"Aaron R.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayme E.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Harmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Cates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aubrey E.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.josat.2023.209153_bb0005","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.addbeh.2011.01.030","article-title":"Counselor attitudes toward the use of naltrexone in substance abuse treatment: A multi-level modeling approach","volume":"36","author":"Abraham","year":"2011","journal-title":"Addictive Behaviors"},{"issue":"4","key":"10.1016\/j.josat.2023.209153_bb0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/ADM.0b013e3181c816f3","article-title":"Psychiatrist characteristics that influence use of buprenorphine medication-assisted treatment","volume":"4","author":"Albright","year":"2010","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209153_bb0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/08897077.2015.1062457","article-title":"Counselor training and attitudes toward pharmacotherapies for opioid use disorder","volume":"37","author":"Aletraris","year":"2016","journal-title":"Substance Abuse"},{"issue":"10","key":"10.1016\/j.josat.2023.209153_bb0025","article-title":"Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence","volume":"2011","author":"Amato","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.josat.2023.209153_bb0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jval.2020.08.2098","article-title":"Disparities in access to opioid treatment programs and office-based buprenorphine treatment across the rural-urban and area deprivation continua: A US nationwide small area analysis","volume":"24","author":"Amiri","year":"2021","journal-title":"Value in Health"},{"issue":"8","key":"10.1016\/j.josat.2023.209153_bb0035","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/add.14946","article-title":"Acceptability and efficacy of naltrexone for criminal justice-involved individuals with opioid use disorder: A systematic review and meta-analysis","volume":"115","author":"Bahji","year":"2020","journal-title":"Addiction"},{"issue":"Suppl. 8","key":"10.1016\/j.josat.2023.209153_bb0040","first-page":"S235","article-title":"Cost and utilization outcomes of opioid-dependence treatments","volume":"17","author":"Baser","year":"2011","journal-title":"The American Journal of Managed Care"},{"issue":"4","key":"10.1016\/j.josat.2023.209153_bb0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/sw\/50.4.295","article-title":"Social work roles and activities regarding psychiatric medication: Results of a national survey","volume":"50","author":"Bentley","year":"2005","journal-title":"Social Work"},{"issue":"4","key":"10.1016\/j.josat.2023.209153_bb0050","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1037\/pha0000325","article-title":"Attitudes toward opioid use disorder medications: Results from a US national study of individuals who resolved a substance use problem","volume":"28","author":"Bergman","year":"2020","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"4","key":"10.1016\/j.josat.2023.209153_bb0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/ADM.0000000000000400","article-title":"Gaps in the substance use disorder treatment referral process: Provider perceptions","volume":"12","author":"Blevins","year":"2018","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.josat.2023.209153_bb0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1300\/J200v01n04_03","article-title":"The psychology of the psychopharmacology triangle","volume":"1","author":"Bradley","year":"2003","journal-title":"Social Work in Mental Health"},{"issue":"1","key":"10.1016\/j.josat.2023.209153_bb0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/00981389.2012.725457","article-title":"Social workers\u2019 knowledge and perceptions of effectiveness and acceptability of medication assisted treatment of substance use disorders","volume":"52","author":"Bride","year":"2013","journal-title":"Social Work in Health Care"},{"key":"10.1016\/j.josat.2023.209153_bb0075","article-title":"Assessing the degree of urbanisation using a single-item self-report measure: A validation study","volume":"1\u201310","author":"Brinkhof","year":"2022","journal-title":"International Journal of Environmental Health Research"},{"issue":"1","key":"10.1016\/j.josat.2023.209153_bb0080","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/16066359.2022.2101640","article-title":"Social support is associated with reduced stigma and shame in a sample of rural and small urban adults in methadone treatment","volume":"31","author":"Broman","year":"2023","journal-title":"Addiction Research & Theory"},{"issue":"1","key":"10.1016\/j.josat.2023.209153_bb0085","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1080\/08897077.2021.1975872","article-title":"Health professionals\u2019 attitudes toward medications for opioid use disorder","volume":"43","author":"Brown","year":"2022","journal-title":"Substance Abuse"},{"issue":"2","key":"10.1016\/j.josat.2023.209153_bb0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/nad.12044","article-title":"\u201cI\u2019m stuck\u201d: Women\u2019s navigations of social networks and prescription drug misuse in central Appalachia","volume":"19","author":"Buer","year":"2016","journal-title":"North American Dialogue"},{"key":"10.1016\/j.josat.2023.209153_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13722-018-0124-2","article-title":"Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: A social ecological approach","volume":"13","author":"Bunting","year":"2018","journal-title":"Addiction Science & Clinical Practice"},{"issue":"4","key":"10.1016\/j.josat.2023.209153_bb0100","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/10826089709039361","article-title":"Measuring and comparing the attitudes and beliefs of staff working in New York methadone maintenance clinics","volume":"32","author":"Caplehorn","year":"1997","journal-title":"Substance Use & Misuse"},{"issue":"100138","key":"10.1016\/j.josat.2023.209153_bb0105","first-page":"1","article-title":"Experiences of healthcare and substance use treatment provider-based stigma among patients receiving methadone","volume":"6","author":"Carl","year":"2023","journal-title":"Drug and Alcohol Dependence Reports"},{"issue":"3","key":"10.1016\/j.josat.2023.209153_bb0110","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.18549\/PharmPract.2021.3.2406","article-title":"Self-reported vs RUCA rural-urban classification among North Carolina pharmacists","volume":"19","author":"Castle","year":"2021","journal-title":"Pharmacy Practice"},{"author":"Centers for Disease Control","key":"10.1016\/j.josat.2023.209153_bb0115"},{"issue":"5","key":"10.1016\/j.josat.2023.209153_bb0120","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/ALN.0000000000002187","article-title":"New opioid analgesic approvals and outpatient utilization of opioid analgesics in the United States, 1997 through 2015","volume":"128","author":"Chai","year":"2018","journal-title":"Anesthesiology: The Journal of the American Society of Anesthesiologists"},{"year":"2012","series-title":"Practicing harm reduction psychotherapy: An alternative approach to addictions","author":"Denning","key":"10.1016\/j.josat.2023.209153_bb0125"},{"issue":"2","key":"10.1016\/j.josat.2023.209153_bb0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/ADM.0000000000000193","article-title":"A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction","volume":"10","author":"Dugosh","year":"2016","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209153_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsat.2016.08.006","article-title":"Opioid overdose experience, risk behaviors, and knowledge in drug users from a rural versus an urban setting","volume":"71","author":"Dunn","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209153_bb0140","doi-asserted-by":"crossref","unstructured":"Durantini, M. R., Grid for the Reduction,of Vulnerability, & Albarracin, D. (2021). The associations of religious affiliation, religious service attendance, and religious leader norm with support for protective versus punitive drug policies: A look at the states affected by the rural opioid epidemic in the United States. Journal of Rural Mental Health, 45(3), 155\u2013170. doi:https:\/\/doi.org\/10.1037\/rmh0000188.","DOI":"10.1037\/rmh0000188"},{"author":"Evans","key":"10.1016\/j.josat.2023.209153_bb0145"},{"issue":"12","key":"10.1016\/j.josat.2023.209153_bb0150","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jamainternmed.2014.5302","article-title":"Primary care\u2013based buprenorphine taper vs maintenance therapy for prescription opioid dependence: A randomized clinical trial","volume":"174","author":"Fiellin","year":"2014","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.josat.2023.209153_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108350","article-title":"The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017","volume":"218","author":"Florence","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2023.209153_bb0165","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s13181-015-0525-5","article-title":"Naloxone administration in US emergency departments, 2000\u20132011","volume":"12","author":"Frank","year":"2016","journal-title":"Journal of Medical Toxicology"},{"issue":"2","key":"10.1016\/j.josat.2023.209153_bb0170","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11524-022-00610-0","article-title":"Impact of the COVID-19 pandemic on opioid overdose deaths: A spatiotemporal analysis","volume":"99","author":"Ghose","year":"2022","journal-title":"Journal of Urban Health"},{"issue":"7","key":"10.1016\/j.josat.2023.209153_bb0175","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2105\/AJPH.2004.042432","article-title":"Rural definitions for health policy and research","volume":"95","author":"Hart","year":"2005","journal-title":"American Journal of Public Health"},{"year":"2017","series-title":"Introduction to mediation, moderation, and conditional process analysis: A regression-based approach","author":"Hayes","key":"10.1016\/j.josat.2023.209153_bb0180"},{"author":"Health Resources and Services Administration","key":"10.1016\/j.josat.2023.209153_bb0185"},{"issue":"4","key":"10.1016\/j.josat.2023.209153_bb0190","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/swr\/svaa017","article-title":"Participant recruitment in social work: A social media approach","volume":"44","author":"Jones","year":"2020","journal-title":"Social Work Research"},{"issue":"1","key":"10.1016\/j.josat.2023.209153_bb0195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jrh.12260","article-title":"Medication-assisted opioid treatment prescribers in federally qualified health centers: Capacity lags in rural areas","volume":"34","author":"Jones","year":"2018","journal-title":"The Journal of Rural Health"},{"issue":"29","key":"10.1016\/j.josat.2023.209153_bb0200","doi-asserted-by":"crossref","first-page":"940","DOI":"10.15585\/mmwr.mm7129e2","article-title":"Vital signs: Drug overdose deaths, by selected sociodemographic and social determinants of health characteristics\u201425 states and the District of Columbia, 2019\u20132020","volume":"71","author":"Kariisa","year":"2022","journal-title":"Morbidity and Mortality Weekly Report"},{"issue":"2","key":"10.1016\/j.josat.2023.209153_bb0205","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsat.2005.05.002","article-title":"Buprenorphine diffusion: The attitudes of substance abuse treatment counselors","volume":"29","author":"Knudsen","year":"2005","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"9776","key":"10.1016\/j.josat.2023.209153_bb0210","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: A double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.josat.2023.209153_bb0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/ADM.0000000000000858","article-title":"Perinatal OUD treatment provider understandings of rural patients\u2019 experiences","volume":"16","author":"Leiner","year":"2022","journal-title":"Journal of Addiction Medicine"},{"issue":"3","key":"10.1016\/j.josat.2023.209153_bb0220","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/00952990.2019.1694536","article-title":"A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States","volume":"46","author":"Lister","year":"2020","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"404","key":"10.1016\/j.josat.2023.209153_bb0225","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1080\/01621459.1988.10478722","article-title":"A test of missing completely at random for multivariate data with missing values","volume":"83","author":"Little","year":"1988","journal-title":"Journal of the American Statistical Association"},{"issue":"3","key":"10.1016\/j.josat.2023.209153_bb0230","doi-asserted-by":"crossref","DOI":"10.29115\/SP-2017-0015","article-title":"Tailored explanation: A strategy to minimize nonresponse in demographic items among low-income racial and ethnic minorities","volume":"10","author":"Lor","year":"2017","journal-title":"Survey Practice"},{"key":"10.1016\/j.josat.2023.209153_bb0235","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews."},{"author":"Mattson","key":"10.1016\/j.josat.2023.209153_bb0240"},{"issue":"1","key":"10.1016\/j.josat.2023.209153_bb0245","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/ADM.0000000000001050","article-title":"Assessing motivations for nonprescribed buprenorphine use among rural Appalachian substance users","volume":"17","author":"McDonald","year":"2023","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2023.209153_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2022.114992","article-title":"Geographic disparities in access to medication for opioid use disorder across US census tracts based on treatment utilization behavior","volume":"302","author":"Mitchell","year":"2022","journal-title":"Social Science & Medicine"},{"year":"2019","series-title":"Medications for opioid use disorder save lives","author":"National Academies of Sciences, Engineering, and Medicine","key":"10.1016\/j.josat.2023.209153_bb0010"},{"author":"National Association for Alcoholism and Drug Abuse Counselors","key":"10.1016\/j.josat.2023.209153_bb0255"},{"author":"National Association of Social Workers","key":"10.1016\/j.josat.2023.209153_bb0260"},{"issue":"14","key":"10.1016\/j.josat.2023.209153_bb0265","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/jama.2014.2147","article-title":"Confronting the stigma of opioid use disorder\u2014And its treatment","volume":"311","author":"Olsen","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.josat.2023.209153_bb0270","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/jrh.12364","article-title":"Concordance of rural-urban self-identity and ZIP code-derived rural-urban commuting area (RUCA) designation","volume":"36","author":"Onega","year":"2020","journal-title":"The Journal of Rural Health"},{"issue":"4","key":"10.1016\/j.josat.2023.209153_bb0275","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/ADM.0000000000000491","article-title":"\u201cI didn\u2019t want to be on suboxone at first\u2026\u201d\u2013ambivalence in perinatal substance use treatment","volume":"13","author":"Ostrach","year":"2019","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209153_bb0280","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/10911359.2018.1472703","article-title":"Secondary traumatic stress and self-care inextricably linked","volume":"29","author":"Owens-King","year":"2019","journal-title":"Journal of Human Behavior in the Social Environment"},{"issue":"12","key":"10.1016\/j.josat.2023.209153_bb0285","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1080\/10826084.2022.2115853","article-title":"Attitudes toward medication for opioid use disorder among substance use treatment providers","volume":"57","author":"Pasman","year":"2022","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.josat.2023.209153_bb0290","unstructured":"Public Religion Research Institute & American Communities Project. (2022). Religious stereotypes vs. reality in urban, suburban, and rural America. https:\/\/www.americancommunities.org\/religious-stereotypes-vs-reality-in-urban-suburban-and-rural-america\/."},{"year":"2018","series-title":"Qualtrics (version October 2018)","author":"Qualtrics.","key":"10.1016\/j.josat.2023.209153_bb0295"},{"issue":"9991","key":"10.1016\/j.josat.2023.209153_bb0300","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: A randomised, open-label trial","volume":"386","author":"Rich","year":"2015","journal-title":"The Lancet"},{"key":"10.1016\/j.josat.2023.209153_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102704","article-title":"\u201cYou are not clean until you\u2019re not on anything\u201d: Perceptions of medication-assisted treatment in rural Appalachia","volume":"85","author":"Richard","year":"2020","journal-title":"International Journal of Drug Policy"},{"issue":"5","key":"10.1016\/j.josat.2023.209153_bb0310","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.addbeh.2014.01.016","article-title":"Impact of research network participation on the adoption of buprenorphine for substance abuse treatment","volume":"39","author":"Rieckmann","year":"2014","journal-title":"Addictive Behaviors"},{"year":"1995","series-title":"The diffusion of innovations","author":"Rogers","key":"10.1016\/j.josat.2023.209153_bb0315"},{"issue":"3","key":"10.1016\/j.josat.2023.209153_bb0320","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1037\/0893-164X.17.3.203","article-title":"Acceptability and availability of harm-reduction interventions for drug abuse in American substance abuse treatment agencies","volume":"17","author":"Rosenberg","year":"2003","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1016\/j.josat.2023.209153_bb0325","unstructured":"SAPList (2022). Find a substance abuse professional. https:\/\/www.saplist.com\/find-a-sap\/."},{"issue":"8","key":"10.1016\/j.josat.2023.209153_bb0330","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/add.14199","article-title":"Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol\u2019s cost and treatment outcomes registry","volume":"113","author":"Saxon","year":"2018","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.josat.2023.209153_bb0335","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/jama.283.10.1303","article-title":"Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: A randomized controlled trial","volume":"283","author":"Sees","year":"2000","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.josat.2023.209153_bb0340","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/00952990.2011.653426","article-title":"Opioid detoxification and naltrexone induction strategies: Recommendations for clinical practice","volume":"38","author":"Sigmon","year":"2012","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2023.209153_bb0345","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.josat.2023.209153_bb0350","first-page":"1","article-title":"Urban\u2013rural differences in drug overdose death rates, 2020","volume":"440","author":"Spencer","year":"2022","journal-title":"NCHS Data Brief"},{"issue":"1","key":"10.1016\/j.josat.2023.209153_bb0355","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2011.10.016","article-title":"The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: Recent service utilization trends in the use of buprenorphine and methadone","volume":"123","author":"Stein","year":"2012","journal-title":"Drug & Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.josat.2023.209153_bb0360","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1001\/jama.2016.10542","article-title":"Physician capacity to treat opioid use disorder with buprenorphine-assisted treatment","volume":"316","author":"Stein","year":"2016","journal-title":"JAMA"},{"author":"Substance Abuse and Mental Health Services Administration","key":"10.1016\/j.josat.2023.209153_bb0365"},{"key":"10.1016\/j.josat.2023.209153_bb0370","first-page":"1","article-title":"The opioid crisis and the Hispanic\/Latino population: An urgent issue","author":"Substance Abuse and Mental Health Services Administration","year":"2020","journal-title":"Office of Behavioral Health Equity"},{"author":"Substance Abuse and Mental Health Services Administration","key":"10.1016\/j.josat.2023.209153_bb0375"},{"issue":"6","key":"10.1016\/j.josat.2023.209153_bb0380","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1521-0391.2014.12143.x","article-title":"Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency","volume":"23","author":"Suzuki","year":"2014","journal-title":"The American Journal on Addictions"},{"author":"United States Census Bureau","key":"10.1016\/j.josat.2023.209153_bb0390"},{"key":"10.1016\/j.josat.2023.209153_bb0395","unstructured":"United States Department of Agriculture, Economic Research Service. (2017). County typology codes. https:\/\/www.ers.usda.gov\/data-products\/county-typology-codes\/."},{"key":"10.1016\/j.josat.2023.209153_bb0400","unstructured":"United States Department of Agriculture, Economic Research Service. (2023). Rural-urban commuting area codes. https:\/\/www.ers.usda.gov\/data-products\/rural-urban-commuting-area-codes."},{"author":"United States Food and Drug Administration","key":"10.1016\/j.josat.2023.209153_bb0405"},{"key":"10.1016\/j.josat.2023.209153_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103351","article-title":"Legacies of the war on drugs: Next of kin of persons who died of opioid overdose and harm reduction interventions in Philadelphia","volume":"97","author":"Uzwiak","year":"2021","journal-title":"International Journal of Drug Policy"},{"issue":"4","key":"10.1016\/j.josat.2023.209153_bb0415","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jsat.2006.09.003","article-title":"Assessing referrals for pharmacotherapy: A comparison of therapist and client report","volume":"32","author":"Varra","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2023.209153_bb0420","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/1533256X.2018.1450264","article-title":"Appalachian women\u2019s use of substance abuse treatment: Examining the behavioral model for vulnerable populations","volume":"18","author":"Victor","year":"2018","journal-title":"Journal of Social Work Practice in the Addictions"},{"issue":"5","key":"10.1016\/j.josat.2023.209153_bb0425","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1007\/s11469-018-0041-3","article-title":"Systemic issues in the opioid epidemic: Supporting the individual, family, and community","volume":"17","author":"Vincenzes","year":"2019","journal-title":"International Journal of Mental Health and Addiction"},{"issue":"22","key":"10.1016\/j.josat.2023.209153_bb0430","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies \u2014 Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209153_bb0435","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11606-016-3799-7","article-title":"Barriers to post-acute care for patients on opioid agonist therapy: An example of systematic stigmatization of addiction","volume":"32","author":"Wakeman","year":"2016","journal-title":"Journal of General Internal Medicine"},{"issue":"2","key":"10.1016\/j.josat.2023.209153_bb0440","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/10826084.2017.1363238","article-title":"Barriers to medications for addiction treatment: How stigma kills","volume":"53","author":"Wakeman","year":"2018","journal-title":"Substance Use & Misuse"},{"issue":"5","key":"10.1016\/j.josat.2023.209153_bb0445","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: Ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clinical Pharmacology & Therapeutics"},{"key":"10.1016\/j.josat.2023.209153_bb0450","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","article-title":"Treatment utilization among persons with opioid use disorder in the United States","volume":"169","author":"Wu","year":"2016","journal-title":"Drug & Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209153_bb0455","article-title":"The acceptability of non-abstinent treatment goals among clinical social workers in the United States","volume":"1-16","author":"Xin","year":"2022","journal-title":"Journal of Social Work Practice"},{"key":"10.1016\/j.josat.2023.209153_bb0460","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugpo.2019.04.010","article-title":"Fentanyl shock: The changing geography of overdose in the United States","volume":"70","author":"Zoorob","year":"2019","journal-title":"International Journal of Drug Policy"},{"issue":"4","key":"10.1016\/j.josat.2023.209153_bb0465","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/15563650.2020.1805461","article-title":"Physician attitudes on buprenorphine induction in the emergency department: Results from a multistate survey","volume":"59","author":"Zuckerman","year":"2021","journal-title":"Clinical Toxicology"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:39:54Z","timestamp":1762652394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923002047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":90,"alternative-id":["S2949875923002047"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209153","relation":{},"ISSN":["2949-8759"],"issn-type":[{"type":"print","value":"2949-8759"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-prescribing clinicians' treatment orientations and attitudes toward treatments for opioid use disorder: Rural differences","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209153"}}